Role of atypical pathogens in infectious exacerbations of COPD;KOAH infektif alevlenmelerinde atipik patojenlerin rolü

Tuberkuloz ve Toraks

Volumn 55, Issue 4, 2007, Pages 336-341

  Taşbakan, Mehmet Sezai ^a,d,f   Sayiner, Ayça Arzu ^b   Sayiner, Abdullah ^c,e  

^a Gö üs Hastaliklari Klini i   (Turkey)

^b DOKUZ EYLUL UNIVERSITY   (Turkey)

^c EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^d Izmir Ataturk Training and Research Hospital   (Turkey)

^e EGE UNIVERSITY   (Turkey)

^f Ege University ^*  (Turkey)

Author keywords

Chlamydia pneumoniae; Chronic obstructive pulmonary disease; Exacerbation; Mycoplasma pneumoniae

Indexed keywords

ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EVALUATION; DISEASE EXACERBATION; ESCHERICHIA COLI; HUMAN; KLEBSIELLA PNEUMONIAE; LABORATORY TEST; PATHOGENESIS; PROGNOSIS; PSEUDOMONAS AERUGINOSA; TREATMENT RESPONSE;

EID: 36849013491     PISSN: 04941373     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary diseases. Am J Respir Crit Care Med 1995; 152: 77-120.
2. st ed. Sheffield: Europan Respiratory Monograph 1998; 3: 264-77.
3. Ball P, Make B. Acute exacerbation of chronic bronchitis. Chest 1998; 113: 199-204.
4. Moǧulkoç N, Karakurt S, Isalska B, et al. Acute purulent exacerbation of COPD and Chlamydia pneumoniae infection. Am J Respir Crit Care Med 1999; 160; 349-53.
5. Karnak D, Beng- sun S, Beder S, Kayacan O. Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med 2001; 95: 811-6.
6. Başoǧlu ÖK, Saymer AA, Zeytinoǧlu A, Sayiner A. The role of atypical bacteria in acute execerbations of chronic obstructive pulmonary disease. Turkish Respiratory Journal 2005; 6: 22-7.
7. Von Hertzen L, Toyryla M, Gimishanov A. Asthma, atopy and Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy 1999; 29: 52-8.
8. Lieberman D, Lieberman D, Ben-Yaakov M, et al. Serological evidence of Mycoplasma pneumoniae infection in acute exacerbation of COPD. Diagn Microbiol Infect Dis 2002; 44: 1-6.
9. Lieberman D, Ben-Yaakov M, Lazarovich L, et al. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: Analysis of 250 hospitalizations. Eur J Clin Microbiol Infect Dis 2001; 20: 698-704.
10. Mundy LM, Oldach D, Auwaerter PG. Implications for macrolide treatment in commumity-acquired pneumoniae. Hopkins CAP Team. Chest 1998; 113: 1201-6.
11. Eller j, Ede A, Schaberg T, et al. Infective exacerbations of chronic bronchitis. Chest 1998; 113: 1542-8.
12. Sayiner A, Okyay N, Unsal I, Colpan N. Infective exacerbations of COPD. Chest 1999; 115: 1481.
13. Johnston SL. The role of viral and atypical bacterial pathogens in astma patogenesis. Pediatr Pulmonol 1999; 18: 141-3.
14. Von Hertzen L, Toyryla M, Gimishanov A. Astma, atopy and Chlamydia pneumoniae antibodies in adults. Clin Exp Allergy 1999; 29: 522-8.
15. Kraft M, Cassel GH, Henson JE. Detection of Mycoplasma pneumoniae in the airways of adults with chronic asthma. Am J Respir Crit Care Med 1998; 158: 998-1001.
16. Branden E, Koyi H, Gnarpe J, et al. Chronic Chlamydia pneumoniae infection is a risk factor fort he development of COPD. Respir Med 2005; 99: 20-6.
17. DeBey MC, Ross RF. Ciliostasis and loss of cilia induced by Mycoplasma hyopneumoniae in porcine tracheal organ cultures. Infect Immun 1994; 62: 5312-8.
18. Shemer-Avni Y, Lieberman D. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis 1995; 171: 1274-8.
19. Blast F, Damato S, Cosentini R, et al. Chlamydia pneumoniae and chronic bronchitis: Association with severity and bacterial clearance following treatment. Thorax 2002; 57: 672-6.